Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Generation Bio Co. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
GBIO
Nasdaq
2834
generationbio.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Generation Bio Co.
XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.
- Feb 9th, 2026 7:53 am
NodThera Appoints Geoff McDonough, M.D., as Chief Executive Officer
- Feb 4th, 2026 6:00 am
Satellos Appoints Antoinette Paone as Chief Development Officer and Head of Regulatory Affairs
- Jan 29th, 2026 5:00 am
NodThera Appoints Geoff McDonough, M.D., as Independent Board Member
- Dec 16th, 2025 6:00 am
‘Zombie’ biotech buyer Xoma to acquire Generation Bio
- Dec 16th, 2025 1:03 am
XOMA Royalty Enters into Agreement to Acquire Generation Bio
- Dec 15th, 2025 3:00 pm
Here's Why We're A Bit Worried About Generation Bio's (NASDAQ:GBIO) Cash Burn Situation
- Dec 2nd, 2025 6:19 am
Generation Bio Announces Third Quarter 2025 Financial Results
- Nov 5th, 2025 2:05 pm
Generation Bio Announces CEO Transition
- Oct 22nd, 2025 2:05 pm
Precigen wins immunotherapy approval; Pfizer sickle cell drug fails trial
- Aug 15th, 2025 5:20 am
Sector Update: Health Care Stocks Climb Late Afternoon
- Aug 13th, 2025 1:56 pm
Generation Bio Shares Surge Following Restructuring Plans, Q2 Results
- Aug 13th, 2025 10:08 am
Generation Bio Co. (GBIO) Reports Q2 Loss, Misses Revenue Estimates
- Aug 12th, 2025 3:30 pm
Generation Bio Announces New Data for Its Novel ctLNP Delivery System and Early T Cell Programs and Reports Second Quarter 2025 Financial Results
- Aug 12th, 2025 2:05 pm
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Beats Revenue Estimates
- Aug 12th, 2025 1:00 pm
Generation Bio Announces 1-for-10 Reverse Stock Split
- Jul 18th, 2025 6:35 am
Generation Bio Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
- Jul 7th, 2025 2:05 pm
We're Keeping An Eye On Generation Bio's (NASDAQ:GBIO) Cash Burn Rate
- Jun 25th, 2025 5:39 am
Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference
- May 28th, 2025 4:59 am
Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates
- May 7th, 2025 3:35 pm
Scroll